Cade Jobsis, 4, scheduled to receive novel gene therapy next month

Cade Jobsis, 4, scheduled to receive novel gene therapy next month

Following a month-long community fundraising effort last year to cover $1.15 million in hospital and regulatory fees, 4-year-old Cade Jobsis was selected for a phase 3 clinical trial underway in Dallas. “When we had heard that it was getting up and running, they were getting through the final phases, we just wanted to be available and give them every opportunity to say, ‘You know, we would love for Cade to be selected,’” said his mother, Emma Jo…